Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "AmMax-Bio"

1 News Found

AmMax Bio licenses Lonza’s ADC tech to advance AML candidate AMB-104
News | June 10, 2026

AmMax Bio licenses Lonza’s ADC tech to advance AML candidate AMB-104

The company gets access to Lonza’s clinically validated SYNtecan linker-payload platform as it prepares an IND filing for its acute myeloid leukemia therapy in 2027